유방암 환자의 항우울제 처방 현황 및 영향요인 연구

키워드

참고문헌 (36)

1. Hortobagyi GN, "The global breast cancer burden: variations in epidemiology and survival", Clin Breast Cancer, 6, pp.391~401 (2005)
2. Pike MC, "Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk", Epidemiol Rev, 15, pp.17~35 (1993)
3. Thurfjell EL, "Breast cancer survival rates with mammographic screening: similar favorable survival rates for women younger and those older than 50 years", Radiology, 201, pp.421~426 (1996)
4. Tristant H, "Effect of breast cancer screening on mortality", pp.1881~ (1999), Presse Med
5. Fann JR, "Major depression after breast cancer : a review of epidemiology and treatment", Gen Hosp Psychiatry, 30, pp.112~126 (2008)
6. Colleoni M, "Depression and degree of acceptance of adjuvant cytotoxic drugs", Lancet, 356, pp.1326~1327 (2000)
7. DiMatteo MR, "Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence", Arch Intern Med, 160, pp.2101~2107 (2000)
8. Satin JR, "Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis", Cancer, 115, pp.5349~5361 (2009)
9. Fallowfield L, "Psychiatric morbidity and its recognition by doctors in patients with cancer", Br J Cancer, 84, pp.1011~1015 (2001)
10. Sharpe M, "Major depression in outpatients attending a regional cancer centre: screening and unmet treatment needs", Br J Cancer, 90, pp.314~320 (2004)
11. Christensen S, "Prevalence and risk of depressive symptoms 3-4 months post-surgery in a nationwide cohort study of Danish women treated for early stage breast-cancer", Breast Cancer Res Treat, 113, pp.339~355 (2009)
12. Kim SH, "Fatigue and depression in disease-free breast cancer survivors: prevalence, correlates, and association with quality of life", J Pain Symptom Manage, 35, pp.644~655 (2008)
13. Bardwell WA, "Objective cancer-related variables are not associated with depressive symptoms in women treated for early-stage breast cancer", J Clin Oncol, 24, pp.2420~2427 (2006)
14. Burgess C, "Depression and anxiety in women with early breast cancer: five year observational cohort study", BMJ, 330, pp.702~ (2005)
15. Azzone V, "Behavioral health services for women who have breast cancer", J Clin Oncol, 27, pp.706~712 (2009)
16. Ashbury FD, "Antidepressant prescribing in community cancer care", Support Care Cancer, 11, pp.278~285 (2003)
17. Aapro M, "Depression in breast cancer patients : the need for treatment", Ann Oncol, 10, pp.627~636 (1999)
18. Monti DA, "Practical geriatrics: depression, cognition, and anxiety among postmenopausal women with breast cancer", Psychiatr Serv, 56, pp.1353~1355 (2005)
19. Leedham B, "Psychosocial concerns and quality of life in breast cancer survivors", Cancer Invest, 17, pp.342~348 (1999)
20. Duffy LS, "Iatrogenic acute estrogen deficiency and psychiatric syndromes in breast cancer patients", Psychosomatics, 40, pp.304~308 (1999)
21. Suppli NP, "Factors associated with the prescription of antidepressive medication to breast cancer patients", Acta Oncol, 50, pp.243~251 (2011)
22. Aziz NM, "Trends and advances in cancer survivorship research : challenge and opportunity", Semin Radiat Oncol, 13, pp.248~266 (2003)
23. Pirl WF, "Diagnosis and treatment of depression in cancer patients", Oncology, 13, pp.1293~1301 (1999)
24. Passik SD, "Oncologists' recognition of depression in their patients with cancer", J Clin Oncol, 16, pp.1594~1600 (1998)
25. Thompson DS, "Mirtazapine for the treatment of depression and nausea in breast and gynecological oncology", Psychosomatics, 41, pp.356~359 (2000)
26. Hjerl K, "Depression as a prognostic factor for breast cancer mortality", Psychosomatics, 44, pp.24~30 (2003)
27. Watson M, "Influence of psychological response on survival in breast cancer: a population-based cohort study", Lancet, 354, pp.1331~1336 (1999)
28. Somerset W, "Breast cancer and depression", Oncology, 18, pp.1021~1034 (2004)
29. Wong-Kim EC, "Depression experienced by young women newly diagnosed with breast cancer", Psychooncology, 14, pp.564~573 (2005)
30. Sellick SM, "Depression and cancer: an appraisal of the literature for prevalence, detection, and practice guideline development for psychological interventions", Psychooncology, 8, pp.315~333 (1999)
31. Pies R, "Psychotropic medications and the oncology patient", Cancer Pract, 4, pp.164~166 (1996)
32. Leopold KA, "Prevalence of mood disorders and utility of the PRIME-MD in patients undergoing radiation therapy", Int J Radiat Oncol Biol Phys, 42, pp.1105~1112 (1998)
33. Stearns V, "Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine", J Natl Cancer Inst, 95, pp.1758~1764 (2003)
34. Johnson MD, "Pharmacological characterization of 4-hydroxy-N-desmethyl tamoxifen, a novel active metabolite of tamoxifen", Breast Cancer Res Treat, 85, pp.151~159 (2004)
35. Borges S, "Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implication for optimization of breast cancer treatment", Clin Pharmacol Ther, 80, pp.61~74 (2006)
36. Henry NL, "Drug interactions and pharmacogenomics in the treatment of breast cancer and depression", Am J Psychiatry, 165, pp.1251~1255 (2008)

관련 논문AI추천